STOCK TITAN
  1. Home
  2. News
  3. TEVA

Teva- Pharmaceutical Industries Ltd. - TEVA STOCK NEWS

IMPACT
SENTIMENT
TEVA : NYSE
Teva Phase IV UNITE Study Shows AJOVY® (fremanezumab) Reduced Migraine Attacks and Depression Symptoms in Migraine Sufferers with Major Depressive Disorder
clinical trial
IMPACT
SENTIMENT
TEVA : NYSE
Teva Leverages Market-leading Temperature & Theft Tracking from FourKites to Deliver Critical Medicines Around the World
IMPACT
SENTIMENT
TEVA : NYSE
Teva to Host Conference Call to Discuss Third Quarter 2023 Financial Results at 8 a.m. ET on November 8, 2023
conferences earnings
IMPACT
SENTIMENT
TEVA : NYSE SNY : Nasdaq
Sanofi and Teva Announce Exclusive Collaboration to Deliver Inflammatory Bowel Disease Treatment
IMPACT
SENTIMENT
TEVA : NYSE
Teva Announces Changes to Executive Management Team
IMPACT
SENTIMENT
TEVA : NYSE
Teva to Present at the 21st Annual Morgan Stanley Global Healthcare Conference
conferences
IMPACT
SENTIMENT
TEVA : NYSE
Teva to Present Data for AUSTEDO® XR (deutetrabenazine) Extended-Release Tablets, AUSTEDO® (deutetrabenazine) Tablets and UZEDY™ (risperidone) Extended-Release Injectable Suspension at Psych Congress 2023
conferences
IMPACT
SENTIMENT
TEVA : NYSE
Teva Settles Price Fixing Charges With U.S. DOJ
IMPACT
SENTIMENT
TEVA : NYSE
Teva Reports Second Quarter 2023 Financial Results
earnings
IMPACT
SENTIMENT
TEVA : NYSE
Teva Announces Appointment of Dr. Angus Grant to Executive Vice President, Business Development
management
Stock TEVA logo
Teva- Pharmaceutical Industries Ltd.
NYSE:TEVA

TEVA Stock Data

Pharmaceutical Preparation Manufacturing
Manufacturing
Link

About TEVA

Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company with headquarters in Tel Aviv, Israel. It specializes primarily in generic drugs, but other business interests include active pharmaceutical ingredients and, to a lesser extent, proprietary pharmaceuticals.